Summary
Ecolab Inc. (ECL) reported a strong first quarter for 2003, demonstrating significant year-over-year growth. Net sales increased by 11% to $875.8 million, driven by organic growth, acquisitions, and a favorable currency translation impact. The company's profitability saw a substantial improvement, with net income rising 58% to $55.3 million, translating to a diluted EPS of $0.42, up from $0.27 in the prior year. This earnings growth was bolstered by improved gross profit margins due to product mix and cost reduction efforts, alongside effective cost controls in selling, general, and administrative expenses. Comparisons to the prior year's first quarter were impacted by significant one-time events in 2002, including restructuring charges and a curtailment gain, which skewed profitability metrics. For 2003, Ecolab is realizing cost savings from previous restructuring initiatives, with a portion being reinvested into the business to fuel growth. The company also saw increased investments in sales and service, along with higher healthcare costs. Ecolab maintained a solid financial position, with total assets increasing and a healthy debt-to-capitalization ratio.
Key Highlights
- 1Consolidated net sales increased 11% to $875.8 million for Q1 2003 compared to Q1 2002.
- 2Net income grew significantly by 58% to $55.3 million, with diluted EPS rising to $0.42 from $0.27.
- 3Gross profit margin improved to 50.8% in Q1 2003 from 49.6% in Q1 2002 (50.3% excluding restructuring charges).
- 4Selling, general, and administrative expenses as a percentage of sales increased slightly to 39.3% from 38.8%, attributed to acquisitions and investments.
- 5The company realized $7.5 million in restructuring savings in Q1 2003, with expectations of $25-$30 million pre-tax annual savings.
- 6Total assets increased to $3.01 billion, driven by acquisitions and currency exchange rate effects.
- 7The company reported adopting SFAS No. 142, discontinuing amortization of goodwill and indefinite-lived intangibles, and took a $4.0 million impairment charge in Q1 2002 related to this adoption.